I-PASS Patient Safety Program to be Implemented at The NIH Clinical Center.
M2 PHARMA-November 16, 2017-I-PASS Patient Safety Program to be Implemented at The NIH Clinical Center
(C)2017 M2 COMMUNICATIONS
- US-based National Institutes of Health Clinical Center has awarded US-based of cloud-based safety intervention implementation tools provider I-PASS Patient Safety Institute, Inc. a contract to help implement and sustain the use of the I-PASS standardized handoff method, including training clinical staff on its use, the company said.
An estimated 80% of the most serious medical errors can be linked to communication failures, particularly during patient handoffs.
Handoffs occur at all changes of shift and whenever a patient changes location in a hospital. In a large, multi-center study published in the New England Journal of Medicine, implementation of I-PASS was associated with a 30% reduction in medical errors that harm patients.
According to the company, the I-PASS Patient Safety Institute makes it easier to implement the validated I-PASS handoff program to reduce communication failures and ensure safer care for patients.
The I-PASS Patient Safety Institute provides hospitals with customized training, expert consultation and cloud-based, technology-enabled tools to facilitate adoption of I-PASS and ensure long-term sustainment.
The I-PASS Patient Safety Institute will help the NIH Clinical Center train their medical professionals with this standardized process as well as initiate metrics and benchmarking to enhance sustainment.
The company was created to help hospitals adopt safer handoff practices across disciplines and units as efficiently and effectively as possible.
The I-PASS programme is now being used by more than 60 leading hospitals in the US.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 16, 2017|
|Previous Article:||Meditech Launches Cloud-Based Electronic Health Record Subscription.|
|Next Article:||Alcyone Lifesciences passes US FDA's clearance for the Alivio System for hydrocephalus.|